Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
GENNEX Stock Analysis
Views
Red Flags
Positive
Stock is reasonably valued and PE TTM is at a discount to industry median
Strong revenue growth and above median growth of industry
Low Debt to Equity, not much change from last year
Negative
Low and declining ROE
Moderate operating margin but declining trend
Company's earnings are of low quality
Low dividend yield
Neutral
Low EPS growth but above median growth of industry
No red flags found!
No significant red flags found in the stock.
Snapshot
See detailed analysis
GENNEX Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
GENNEX Bulk, Block & Insider Trades
GENNEX Dividends, Splits & Bonus
Dividend Events
Capital Change Events
No dividend events found
Rights issue
Stock split
Rights issue(1 new shares @ 6 INR for 2 existing shares) Ex-date: 21st Jul 2022 Announced on: 16th Jul 2022
Stock split(1 : 10)EGM 31 October 2009. Nominal value change from Rs 10 to Rs 1. Ex-date: 14th Dec 2009 Announced on: 10th Sep 2009
Company Profile
Gennex Laboratories Limited is an India-based active pharmaceutical ingredient manufacturing company. The Company is engaged in the business of manufacturing of bulk drugs and intermediaries. It offers products in various therapeutic categories, including expectorant (mucolyte), relaxant (skeletal m... Read More
Key personnel
Shri. K. V. L. N. Bhaswanth
Chief Operating Officer, Compliance Officer
Shri. Arihant BaidD
Managing Director, Director
Shri. Tiruvarur Muralidharan GopalakrishnanD
Whole Time Director
Shri. U. C. BhandariD
Non-Executive Independent Director
Mr. Yellu Ravinder ReddyD
Non-Executive Independent Director
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Gennex Laboratories Ltd.?
The current share price of Gennex Laboratories Ltd. is ₹ 13.56 as of 09 Jan 2026.
What is the PE ratio of Gennex Laboratories Ltd.?
The Price-to-Earnings (PE) ratio of Gennex Laboratories Ltd. is 15.85 as of the latest financial data.
What is the ROE and ROCE of Gennex Laboratories Ltd.?
Gennex Laboratories Ltd. has a Return on Equity (ROE) of 9.88% and a Return on Capital Employed (ROCE) of 7.28% as per the latest financial reports.
What is the market cap of Gennex Laboratories Ltd.?
The market capitalization of Gennex Laboratories Ltd. stands at ₹ 308.42 Cr.
What is the dividend yield of Gennex Laboratories Ltd.?
The dividend yield of Gennex Laboratories Ltd. is 0.00% based on the current market price.
What is the RSI of Gennex Laboratories Ltd.?
The Relative Strength Index (RSI) of Gennex Laboratories Ltd. is 48.97.
What is the FII and DII holding in Gennex Laboratories Ltd.?
Foreign Institutional Investors (FII) hold 0.00% and Domestic Institutional Investors (DII) hold 0.00% of Gennex Laboratories Ltd. shares.
What sector does Gennex Laboratories Ltd. belong to?
Gennex Laboratories Ltd. operates in the Healthcare sector.
What is the beta of Gennex Laboratories Ltd. stock?
The beta of Gennex Laboratories Ltd. stock is 1.19, indicating its volatility relative to the broader market.
